(OTCQX: VXRT) ("Vaxart” or the "Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced its ...
Researchers are still trying to understand why some people develop Long COVID: lasting symptoms of the disease that can ...
In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results